Spero Therapeutics
SPRO
SPRO
69 hedge funds and large institutions have $39.3M invested in Spero Therapeutics in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 20 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
42% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 24
45% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 20
52% less call options, than puts
Call options by funds: $241K | Put options by funds: $504K
Holders
69
Holding in Top 10
1
Calls
$241K
Puts
$504K
Top Buyers
| 1 | +$4.6M | |
| 2 | +$2.95M | |
| 3 | +$1.52M | |
| 4 |
Millennium Management
New York
|
+$748K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$301K |
Top Sellers
| 1 | -$3.84M | |
| 2 | -$2.32M | |
| 3 | -$1.45M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$550K |
| 5 |
Goldman Sachs
New York
|
-$496K |